Clinical Trials Logo
  1. Home
  2. Systemic Lupus
  3. NCT04894253

Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus — LUPCELLVAX  

Systemic Lupus Clinical Trial

Official title:
Study of the Immune Response to SARS-CoV-2 Vaccination in Patients With Systemic Lupus

Clinical Trial Summary

The main objective is to study the impact of vaccination against Covid-19 on the specific humoral and cellular immune response (against SARS-CoV-2) and non-specific (evolution of the pathological immune system of the disease), in a lupus population. The secondary objective is to study the impact of lupus disease activity on the humoral and cellular response of patients following vaccination against SARS-CoV-2. The hypothesis is that disease activity and / or certain treatments used in lupus may interfere with the humoral and cellular immune response induced by vaccination against SARS-CoV-2.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04894253
Study type Observational [Patient Registry]
Source University Hospital, Strasbourg, France
Contact Jean SIBILIA, MD
Phone 3 88 12 79 55
Email jean.sibilia@chru-strasbourg.fr
Status Recruiting
Phase
Start date June 7, 2021
Completion date February 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT03749044 - ASA Patterns for Prevention of Preeclampsia in SLE Pregnancies N/A
Completed NCT03218033 - Use of Social Media to Improve Medication Adherence in Adolescents and Young Adults With Systemic Lupus N/A
Not yet recruiting NCT03752983 - Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE
Recruiting NCT03819777 - Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)
Not yet recruiting NCT03164720 - SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis
Completed NCT03762824 - Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease Phase 4
Not yet recruiting NCT06435468 - Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases N/A
Terminated NCT01738360 - Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC) Phase 2
Completed NCT03430388 - Yellow Fever Vaccine in Patients With Rheumatic Diseases N/A
Completed NCT04108611 - Immune Adsorption Role in Treatment of Resistant Lupus N/A
Not yet recruiting NCT04256577 - Serum Ceramides Level in Systemic Lupus Erythematosus (SLE) Patients as a Novel Marker for Renal Impairment
Completed NCT03540823 - Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases Phase 4